AstraZeneca PLC - Depreciation

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Depreciation" stands at 6.34 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the highest value since 09/30/2022.

AstraZeneca PLC's second quarter result of 1.92 Billion USD for the item "Depreciation" represents an increase of 40.36 percent compared to it's first quarter result.

Also, AstraZeneca PLC's second quarter result of 1.92 Billion USD for the item "Depreciation" represents an increase of 38.04 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's second quarter result of 6.34 Billion USD for the item "Depreciation" represents an increase of 9.09 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 21.89 percent compared to the value the year prior.
The 1 year change in percent is 21.89.
The 3 year change in percent is 13.44.
The 5 year change in percent is 119.11.
The 10 year change in percent is 159.65.

The Serie's long term average value is 4.10 Billion United States Dollars. It's latest available value, on 06/30/2026, is 54.63 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2026, is +169.13%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 06/30/2026, is -17.04%.